The aetiology of central post-stroke pain (CPSP) is poorly understood and such pains are often refractory to treatment. We report the case of a 56-year-old man, who, following a temporo-parietal infarct, suffered from debilitating and refractory hemi-body cold dysaesthesia and severe tactile allodynia. This was associated with thermal and tactile hypoaesthesia and hypoalgesia on his affected si...

The deep inferior epigastric artery (DIEA) perforator (DIEP) flap has been widely described as a safe flap with reliable vascular anatomy. One of its limitations is potentially lengthy operating times during flap harvest, and many techniques have been reported to reduce operating times. One such technique is the preoperative selection of perforators with imaging, which has been shown to substan...

introduction: deep neck space infections (dnsi) are serious diseases that involve several spaces in the neck. the common primary sources of dnsi are dental infections, tonsillar and salivary gland infections, malignancies, and foreign bodies. with widespread use of antibiotics, the prevalence of dnsi has been reduced. common complications of dnsi include airway obstruction, jugular vein thrombo...

Introduction: The degree of polymerization depends on the type of light-curing unit. The aim of this study was to compare the hardness of composite resin cured by LED and Halogen light curing units. Methods: In this experimental study, 20 cylindrical samples of Tetric Ceram composite were prepared. Half of them were cured with Ultralume 2 LED and the other half with Astralis 7 Halogen light ...

Streptokinase is a potent fibrinolytic agent which is widely used in treatment of deep vein thrombosis (DVT), pulmonary embolism (PE) and acute myocardial infarction (MI). Major limitation of this enzyme is its short biological half-life in the blood stream. Our previous report showed that complexing streptokinase with chitosan could be a solution to overcome this limitation. The aim of this re...

Streptokinase is a potent fibrinolytic agent which is widely used in treatment of deep vein thrombosis (DVT), pulmonary embolism (PE) and acute myocardial infarction (MI). Major limitation of this enzyme is its short biological half-life in the blood stream. Our previous report showed that complexing streptokinase with chitosan could be a solution to overcome this limitation. The aim of this re...